With the $57 million (€50 million), SpliceBio aims to bring this strategy to the clinical phase (human trials) in about 2 to 3 years. Its aim...
Pfizer, Johnson&Johnson (J&J) and AstraZeneca achieved a combined profit of $42.972 billion in 2021, up from $27.017 billion a year earlier, according to results released by...
Based in Granada, Regemat 3D is one of the main players in this new industry. The company manufactures tissue and organ biofabrication systems, bioprinters, and bioreactors,...
The future is closer than we think. We already use intelligent solutions based on AI and machine learning, not even realizing how they make our life...
Spain is considered an attractive market for Medicsen, as this country has the second-highest prevalence rate of diabetes in Europe, according to data from the International...
By 2022, the company Iomed expects to have a turnover of $1.83 million (€1.6 million), which is equivalent to tripling last year's sales. This boom "is...
Despite its desire to expand markets, Adntro already markets its tests in sixty countries on five continents, although the company's priority markets will continue to be...
Almirall, founded in 1943 and headquartered in Barcelona, is listed on the Spanish Stock Exchange and is a member of the Ibex 35. The company currently...
A total of 36 deals were closed in 2021, a lower number compared to the previous year (41), but higher in terms of average amount per...
In the summer, Inuba closed a $1.6 million (€1.4 million) financing round that was used to create the marketing team. Previously, in February 2020, the month...